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Abstract
Background: Sudden death risk in Williams syndrome (WS) patients has been shown to be
25–100 times higher than in the general population. This study aims to detect coronary artery
anomalies and myocardial perfusion defects in WS patients using noninvasive diagnostic
methods.
Methods: This study features 38 patients diagnosed with WS. In addition to physical examina-
tion, electrocardiography, and echocardiography, computed tomography (CT) angiography and
rest/dipyridamole stress technetium-99m sestamibi (99mTc-sestamibi) single photon emission
computed tomography (SPECT) myocardial perfusion scintigraphy (MPS) were performed.
Results: Twenty-one (55%) patients were male; 17 (45%) were female. The average patient
age was 12 ± 5 years (2.5–26 years); the average follow-up period was 7.2 ± 4.2 years
(6 months–18 years). Cardiovascular abnormalities were found in 89% of patients, the most
common one being supravalvar aortic stenosis (SVAS). CT angiography revealed coronary
anomalies in 10 (26%) patients, the most common ones being ectasia of the left main coronary
artery and proximal right coronary artery as well as myocardial bridging. SVAS was present
in 80% of patients with coronary artery anomalies. 99mTc-sestamibi SPECT MPS revealed
findings possibly consistent with myocardial ischemia in 29% of patients, and ischemia in
7 out of 10 patients (70%) with coronary anomalies shown on CT angiography (p = 0.03).
Conclusions: Coronary artery abnormalities are relatively common in WS patients and are
often accompanied by SVAS. CT angiography and dipyridamole 99mTc-sestamibi SPECT MPS
seem to be less invasive methods of detecting coronary artery anomalies and myocardial
perfusion defects in WS patients. (Cardiol J 2012; 19, 3: 301–308)
Key words: Williams syndrome, coronary artery abnormalities, scintigraphy,
computed tomography angiography
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Introduction
Williams syndrome (WS), also known as Wil-
liams-Beuren syndrome, now recognized to be
caused by a microdeletion of chromosome 7q11.23,
is a multisystem disorder first identified as a dis-
tinct clinical entity in 1961 [1, 2]. The incidence is
1 in 10,000 live births [3]. Cardiovascular problems
caused by deletion of the elastin gene are the main
cause of morbidity and mortality and occur in 80–
–85% of all WS patients [2, 4, 5]. While the most
common cardiovascular abnormalities are supraval-
var aortic stenosis (SVAS) and peripheral pulmo-
nary artery stenosis (PAS), any artery can poten-
tially be involved due to a haploinsufficiency of elas-
tin protein [2].
The leading cause of death in WS patients
is sudden cardiac death. A study of approximately
300 cases showed that the risk of sudden death is
25–100 times higher in WS patients than in the ge-
neral population [6]. It has also been shown to be
particularly high in patients who have biventricu-
lar outflow tract stenosis with ventricular hypertro-
phy and those with coronary artery anomalies [7–
–9]. Many deaths have occured during anesthesia/
/sedation (often with cardiac catheterization), sug-
gesting that decreased cardiac output from anes-
thetic agents in concert with coronary artery abnor-
malities altering myocardial perfusion [5, 10].
There are several studies conducted on the
incidence and the course of congenital cardiac
anomalies like SVAS and PAS in WS patients,
whereas studies focusing on coronary artery ano-
malies in WS patients are rare [5]. While some stud-
ies have indicated that coronary artery lesions and
sudden death are linked to the presence and seve-
rity of SVAS, the fact that there are only case re-
ports with isolated left main coronary artery lesions
suggests that this condition may be directly con-
nected to elastin arteriopathy [11–13].
Regardless of the presence of SVAS, there is
always a possibility of coronary artery involvement
in WS patients, which must always be taken into
account in the preoperative period, prior to admin-
istering anaesthesia [9, 10, 14]. In  view of these
reports, in addition to the standard electrocardio-
graphic (ECG) and echocardiographic (ECHO) ex-
aminations, ECG-triggered myocardial perfusion
scintigraphy (MPS) can be performed in order to
assess the severity of coronary lesions [5, 9, 14, 15].
While there are some who even recommend coro-
nary angiography in the preoperative period [10],
the sudden death risk associated with cardiac cath-
eterization is a serious issue [9]. In such cases less
invasive methods like multidetector computed to-
mography (CT) angiography can be used to observe
coronary anatomy (16).
Single photon emission computed tomography
(SPECT) MPS is a useful noninvasive technique for
diagnosing ischemia. As exercise testing cannot be
performed in children with WS, dipyridamole can
be used to induce pharmacologic stress. The sen-
sitivity and specificity of exercise and pharmacolo-
gic stress for SPECT MPS can be considered as
similar in children [17].
In order to evaluate coronary artery abnorma-
lities and myocardial perfusion defects in WS pa-
tients, CT angiography and a dipyridamole stress
test followed by technetium-99m (99mTc) sestamibi
SPECT MPS were performed and this study design
is the first extensure study investigating the occur-
rence of coronary artery anomalies by the use of CT
angiography and MPS in a cohort of WS patients.
Methods
Study population. This study features 38 WS
patients who were followed at our clinics. For each
case, the diagnosis was confirmed by the clinical
phenotype assessed by an experienced medical
geneticist and the typical elastin gene hemizygosi-
ty shown by fluorescence in situ hybridization tech-
nique. This cross-sectional study was carried out
between September 2010 and June 2011. During
this period, all patients underwent detailed cardio-
logical evaluation and all examination findings and
arterial blood pressure values were recorded. In
addition to the standard ECG and ECHO, 99mTc-ses-
tamibi SPECT MPS and CT angiography were per-
formed in all patients. The risks of 99mTc-sestamibi
SPECT MPS and CT angiography were explained
to the families and informed consent was obtained
from all the parents. Approval for this study was
obtained from the ethics committee of the univer-
sity hospital.
Electrocardiogram (ECG). A standard 12-
-lead ECG was obtained at a paper speed of 25 mm/
/sec and an amplitude of 10 mm/mV (Nihon-Kohden
ECG 6511, Tokyo, Japan). On each electrocardio-
gram, we calculated the heart rate, P wave dura-
tion and length, PR interval, QRS duration, and
R and S wave lengths in the V1, V2, V5 and V6 leads
to screen for left and right ventricular hypertrophy
(LVH, RVH) according to age. Electrocardiograms
were also examined for ischemic ST segment
changes and pathological q waves. Bazett’s formu-
la was used to calculate the QTc interval, which was
considered prolonged when ≥ 450 ms [18, 19].
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Echocardiography (ECHO). M-mode, 2D
and color Doppler echocardiography was performed
in all patients (Vivid 3 and Vivid 7 GE, USA). When
measuring the peak systolic instantaneous gradient
between the prestenotic and poststenotic supraval-
var segments, a difference of > 10 mm Hg was con-
sidered an indication of SVAS. The severity of
stenosis was assessed according to Doppler maxi-
mum peak systolic instantaneous gradient measure-
ments: < 25 mm Hg was considered minimal, 25–
–49 mm Hg as mild, 50–75 mm Hg asmoderate and
> 75 mm Hg as severe. Echocardiographically, PAS
diagnosis was considered as localized or diffuse
stenosis in the main pulmonary artery and its
branches in patients with a pressure difference of
> 10 mm Hg in the branches. The severity of steno-
sis was assessed as in right ventricular outflow tract
stenosis [20–22].
CT angiography. A 64-slice multidetector CT
scanner with 400 msec gantry rotation was used for
ECG-triggered angiography (Aquillon 64, Toshiba,
Sweden). Patients with a heart rate of over 100 bpm
were given 1–2 mg/kg metoprolol in order to de-
crease the heart rate. Young children were seda-
ted with midazolam for the procedure. In order to
intravenously deliver the contrast material, an 18G
Intracath catheter was inserted into the antecubit-
al vein. When the non-ionic CT contrast material
delivered at 2 mL/kg and 3–4 mL/s reached maxi-
mum enhancement in the aortic root using bolus
tracking, CT imaging was started.
Images were taken in the axial view, from the
clavicles to the apex of the heart. Coperative pedi-
atric patients were asked to take a deep breath and
hold it. CT images of the heart in the late systolic
and late diastolic phases were reconstructed from
the recorded data of synchronized ECG and CT.
Reconstructed images were generated on a high-
performance workstation (Vitrea 2, Toshiba) from
thin axial slices in the 2D maximum intensity pro-
jection (MIP) and multiplanar reformat (MPR) for-
mats and the 3D volume rendering format. The
MPR and MIP images were used to evaluate ves-
sel walls and lumens and cardiac chambers, while
the 3D images were used to evaluate coronary ar-
tery anatomy.
99mTc-sestamibi SPECT MPS. After a dipy-
ridamole stress test, 99mTc-sestamibi SPECT MPS
was performed. Young children were sedated with
midazolam. Patients received a 4-minute intrave-
nous infusion of dipyridamole at 0.56 mg/kg and
0.142 mg/kg/min, then an intravenous injection of
99mTc-sestamibi on the 7th–8th minute when maxi-
mum vasodilation was achieved, and the test was
finished on the 10th minute. ECG monitoring was
performed during the entire procedure. Thirty min-
utes after the 99mTc-sestamibi injection, the stress
image was taken with the patient in supine position,
starting with a 45° right anterior oblique view and
ending with a 45° left posterior oblique view in
a 180° arc, using a Mediso Nucline SPIRIT DH-V
dual-head gamma camera. The rest image was ta-
ken 3 hours after the stress image. After the stress
and the rest data was processed, the horizontal long
axis, vertical long axis and short axis images were
obtained. Defects were classified as ‘fixed defect
(FD)’ (a defect that was present in both the rest and
the stress SPECT images), ‘transient defect (TD)’
(a defect that was present only in the stress SPECT
image) and ‘reverse defect (RD)’ (a defect that was
present only in the rest SPECT image).
Additionally, using an ADAC Vertex Plus dual-
-head gamma camera, gated SPECT with 3-lead ECG
monitoring was performed after the stress imaging in
coperative patients in order to evaluate left ventricu-
lar function. Left ventricular wall motion, end-systo-
lic and end-diastolic volumes and ejection fractions
were evaluated. The stress and the rest images and
the gated SPECT findings were analyzed together.
The study was approved by the local bioethi-
cal committee and all patients gave their informed
consent.
Statistical analysis
Statistical Package for the Social Science 15.0
for Windows (SPSS, Chicago, IL) was used for data
analysis (reliability, construct validity and internal
consistency). The average values and intervals
were specified as ± SD. As the number of cases was
sufficient for comparing the data on concomitant
congenital cardiac diseases and coronary anomalies,
the chi-square test was used. Sub-group analyses
were performed in order to examine the correlation
between echocardiography, CT angiography and
99mTc-sestamibi SPECT MPS findings. A p value of
< 0.05 was considered significant.
Results
Out of 38 Williams syndrome patients, 21 (55%)
were male and 17 (45%) were female. The average
patient age was 12 ± 5 years (2.5–26 years); the
average follow-up period was 7.2 ± 4.2 years
(6 months–18 years). All patients showed the char-
acteristic dysmorphic feature and typical deletion
on 7q11.23.
Cardiovascular abnormalities. As summa-
rized in Table 1, 34 of 38 (89%) patients had car-
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diovascular abnormalities at of the most recent eva-
luation. The most common ones were: SVAS in
26 (68%) patients, PAS in 15 (39%), and MVP in
10 (26%). Less common anomalies observed were
mild aortic insufficiency in 7 (18%), valvular pulmo-
nary stenosis in 2 (5%), ventricular septal defect in
one (2.6%), bicuspid aorta in one (2.6%) and sub-
aortic discrete membrane in one (2.6%). SVAS was
minimal in 7 (27%) patients, mild in 9 (35%), mode-
rate in 4 (15%) and severe in 6 (23%); those with
severe stenosis underwent surgery. None of the pa-
tients had left ventricular dysfunction or impaired
ejection fraction.
When evaluated cross-sectionally, anomalies
were found on the most recent ECGs of 8 (21%)
patients. Two patients had right atrial dilation, one
patient had RVH, one LVH, one patient right bun-
dle branch block, two showed negative T wave, one
ST segment depression and one pathologic q wave.
The QTc interval was ≥ 450 ms in 3 (7.8%) patients,
one of whom was operated due to severe SVAS, one
had severe PAS and one had severe MVP and mild
mitral valve insufficiency.
CT angiography findings. Echocardiogra-
phically detected SVAS was confirmed in all patients
(Fig. 1). However, the images were insufficient to
investigate patients with PAS, and no meaningful
data could be obtained.
As shown in Table 2, coronary anomalies were
found in 10 (26.3%) patients. Five of them (13%)
had ectasia of the left main coronary artery (LMCA),
two of the right coronary artery (RCA) and one of
the circumflex (Cx) artery. In two patients, LMCA
was absent and the left anterior descending artery
(LAD) and Cx artery originated separately from the
left coronary orifice, while one patient had a hypo-
plastic RCA. In one patient, all coronary arteries
originated from the left coronary orifice, while in
another patient both coronary orifices were locat-
ed above the sinotubular junction and mild LMCA
stenosis was seen. Finally, three patients (7.9%)
had myocardial bridging that was superficial in the
distal segment of LAD in two patients and deep,
3 cm long bridging was shown in the middle seg-
ment of LAD in one patient (Fig. 2).
SVAS was present in 8 out of 10 patients (80%)
with coronary anomalies; SVAS was severe in half
of them and had been corrected surgically. Balloon
valvuloplasty was performed in one patient with
severe valvular pulmonary stenosis. The physical
examination and ECHO for the rest of the patients
were in normal range. Statistically, there was a sig-
nificant correlation between coronary anomalies and
presence of SVAS (p = 0.039), while there was no
statistical significance for the frequency of coronary
anomalies and the severity of SVAS (p > 0.05).
99mTc-sestamibi SPECT MPS findings. As
shown in Table 2, 11 out of 38 patients (29%) had
findings consistent with myocardial ischemia. SVAS
of varying severity was present in 9 of the patients
with ischemia and was accompanied by PAS in two
of them. SVAS was surgically corrected in 3 pa-
tients, 2 of which had minimal residual stenosis.
MPS showed a demarcated area of nonperfusion
Table 1. Cardiovascular findings of 38 Williams
syndrome patients.
Cardiac abnormality 34 (89%)
Stenotic lesions





Pulmonary artery stenosis 15 (39%)
Intracardiac lesions
Mitral valve prolapse 10 (26%)
Ventricular septal defect 1 (2.6%)
Valvular pulmonary stenosis 2 (5%)
Aortic insufficiency 7 (18%)
Bicuspid aorta 1 (2.6%)
Subaortic discrete membrane 1 (2.6%)
Hypertension 10 (26%)
Figure 1. The image, where the left ventricle (LV) and
the ascending aorta (Ao) are observed in the same slice,
shows hourglass-type supravalvar aortic stenosis and
poststenotic dilation (marked by an arrow).
305
Yakup Ergul et al., Coronary artery abnormalities in Williams syndrome
www.cardiologyjournal.org
possibly consistent with infarct in the stress and the
rest images of the apical area of the heart in one of
the ischemic patients who had severe PAS and mild
SVAS (Fig. 3). Ischemia was present in 7 out of the
10 patients (70%) with coronary anomalies seen on
CT angiography, and this correlation was statisti-
Table 2. Coronary CT angiography and dipyridamole 99mTc-sestamibi-SPECT MPS results of
14 patients who exhibit pathological findings.
Patient Age Sex ECG ECHO CT angiography MPS
# [years] (M/F) finding  finding  finding  finding
1 16 M – Balloon valvuloplasty LMCA absent, LAD Ischemia of LV
performed for PS, and Cx originate anteroseptal,
mild residual PS separately, deep anterolateral
bridging in LAD    walls (RD)
2 12 F – Severe SVAS corrected, Proximal segment –
minimal residual SVAS  of LMCA ectatic
(5.6 mm)
3 12 F – Minimal SVAS, LMCA absent, LAD Ischemia of LV
moderate PS and Cx originate anterior wall (RD)
separately, superficial
bridging in LAD
4 7 M – Mild SVAS Both coronary arteries –
originate from left main
coronary orifice
5 10 M RAD, deep Q, Severe PAS, RV – In the apical region,
QTc ≥ 450  dilatation and demarcated
hypertrophy nonperfusion
(RVP 200 mm Hg), and ischemia of
mild SVAS anterolateral LV
possibly consistent
with infarct (FD)
6 16 M QTc ≥ 450 Severe SVAS Proximal segments Ischemia of LV
corrected, minimal of LMCA (6 mm) apical anterolateral
residual SVAS   and RCA (5.7 mm) and lateral
ectatic walls (TD)
7 26 F – Moderate SVAS, – Mild ischemia of LV
mild PAS lateral wall (RD)
8 15 F LVH Severe SVAS Proximal segments Ischemia of LV
corrected, no of LMCA (6.4 mm), anterior wall (RD)
residual stenosis   RCA (5.7 mm) and Cx
(5.4 mm) ectatic
9 14 M – Minimal SVAS, Proximal segment Ischemia of LV
VSD, MVP  of LMCA (5.6 mm), inferolateral
superficial bridging wall (RD)
in LAD
10 12 F – Mild SVAS, MVP Hypoplastic RCA –
11 13 M – – LMCA and RCA Ischemia of
located superiorly, anterolateral LV
mild LAD stenosis    and septum (TD)
12 16 M – Mild SVAS – Ischemia of
inferolaterobasal
LV (RD)
13 7 F – Mild SVAS, – Mild ischemia of LV
mild PAS anteroseptal
wall (RD)
14 21 F – Severe SVAS LMCA short and Ischemia of LV
corrected, minimal ectatic at proximal anterior wall (RD)
residual SVAS end  (5.3 mm)
ECG — electrocardiography; F — female, M — male; CT — computed tomography; MPS — myocardial perfusion scintigraphy; PS — pulmonary stenosis;
SVAS — supravalvar aortic stenosis; PAS —  pulmonary artery stenosis; VSD — ventricular septal defect; LMCA — left main coronary artery;
LAD — left anterior descending artery; Cx — circumflex artery; RCA — right coronary artery; LV — left ventricle; RAD — right atrial dilation;
RV — right ventricle; RVP — right ventricular pressure; MVP — mitral valve prolapse; FD — fixed defect; TD — transient defect; RD — reverse defect
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cally significant (p = 0.03). Ischemia findings were
also detected in 3 patients with myocardial bridg-
ing seen on CT angiography. Notably, while one of
the patients had no pathologies according to physi-
cal examination, ECG and ECHO, coronary CT
angiography showed that both coronary artery ori-
fices were located superiorly as well as LMCA
stenosis, while MPS revealed findings consistent
with ischemia.
We were able to perform gated SPECT in 16 out
of 38 patients who underwent dipyridamole MPS.
In 10 of them, left ventricular ejection fraction was
within normal limits and LV wall motion was found
to be normal, while in the remaining 6 patients it
was considered abnormal.
Discussion
The life expectancy in WS patients has not
been evaluated in comprehensive follow-up stu-
dies, cardiovascular complications are known to be
the most important cause of mortality [4]. The an-
nual risk of sudden death in WS patients has been
found to be 1/1000 [6]. Several reports state that
sudden death generally occurs during or immedi-
ately after the cardiac catheterization procedure [6–
–10]. The largest series on this field is the study
on the sudden death prevalance in 19 patients be-
tween 1 month and 6 years [7]. Elevan patients in
the study, has died due for sudden death occuring
after sedatives or anaesthetics were administered
Figure 3. In a 10-year old male patient with severe peripheral pulmonary artery stenosis and mild supravalvar aortic
stenosis, myocardial perfusion scintigraphy findings consistent with ischemia and an infarct in the apical region of
the heart.
Figure 2. Two-dimensional (A) and three-dimensional (B) coronary computed tomography angiography images
revealed deep myocardial bridging in the middle segment of the left anterior descending branch (LAD).
A B
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during cardiac catheterization or surgery. Postmor-
tem examinations had showed coronary anomalies
in 14 patients, biventricular outflow tract stenosis
in 9 patients and both in 7 patients. Although sud-
den death seems to ocur exclusively during car-
diac catheterization, there are two important points
to be considered. Initially, catheter manipulations
destabilize hemodynamics, trigger arrythmia and in-
crease outlfow tract stenosis. Ischemia and arryth-
mia can also be triggered by the decrease of coro-
nary blood flow during aortic root injection or coro-
nary imaging. Second factor is that the anaesthetic
agents can also disrupt hemodynamics and lead to
death [5, 9, 10].
In order to predict the risk of sudden death in
WS patients, it is always important evaluate fort he
possible coronary lesions [5]. At this end, myocar-
dial perfusion scintigraphy and angiography can be
used in addition to standard ECG and ECHO [9, 10,
14, 23]. While some authors recommend perform-
ing cardiac catheterization and coronary angiogra-
phy prior to surgery, these procedures can them-
selves cause sudden death [9, 10]. Furthermore, the
dysmorphic facial features of WS patients may com-
plicate intubation and tracheal ventilation, while
concomitant endocrine and nephrological disorders
may trigger anaesthesia-related complications [15,
24, 25]. Thus, there is a need for less invasive im-
aging methods that would allow to detect coronary
lesions. The quality of the images obtained by mag-
netic resonance angiography produced is still insuf-
ficient for evaluation of coronary anatomy. Multide-
tector CT angiography, on the other hand, can be
used to obtain more clear 3D images of coronary
arteries as well as the aorta and its main branches,
in children as well [16]. As of yet, there have not
been any studies that use CT angiography to ex-
amine coronary lesions in WS patients. In a study
which conventional angiography was used, the rate
of ectasia and stenosis of coronary arteries in 26 WS
patients was 27%; sinotubular junctions were found
to be more narrow and the difference in pressures
between the left ventricle and the artery above the
sinotubular junction was larger in patients with cor-
onary artery anomalies [11]. In our study, by coro-
nary CT angiography coronary artery anomalies has
been revealed in one fourth of all patients. None of
our patients developed any complications related to
the procedure. In most patients LMCA was ectatic.
Notably, 80% of patients with coronary anomalies
had SVAS, and half of them required surgery. This
fact supports the theory that coronary artery anoma-
lies in WS patients are often accompanied by SVAS
and when coronary ostiums are faced with preste-
notic pressure, it can trigger accelerated atheroscle-
rosis, dilatation or aneurysms [5, 9, 10, 14, 26].
One important finding in our study is the pre-
viously unmentioned myocardial bridging, which
was observed in 8% of our WS patients. While it is
a relatively common condition in the general popu-
lation, myocardial bridging may not constitute a cli-
nical sign when very superficial, but can lead to is-
chemia when deep and even necessitate myotomy
if there is a distal infarction [27, 28].
MPS can be used to investigate ischemia in WS
patients if there are clinical, electrocardiographic or
imaging findings that suggest coronary artery anoma-
lies or ischemia.  In children and patients with neu-
romotor retardation whose cooperation in exercise
stress testing is suboptimal, pharmacological stress
agents like dipyridamole can be administered [17, 29,
30]. In patients with suspected coronary anomalies,
SPECT or PET MPS can help fort he final decision
whether coronary angiography is needed, show myo-
cardial viability and evaluate myocardial blood flow
under conditions like physical activity [17, 31]. As
atherosclerosis is very rare in children, the uses of
MPS are limited. It is generally used in patients with
diseases causing coronary artery stenosis and aneu-
rysms, particularly in Kawasaki disease. Less fre-
quently, MPS can be used in coronary fistulas, car-
diomyopathies, and coronary artery anomalies con-
comitant with isolated or congenital cardiac diseases
[17, 29–33]. The exception of being case reports,
studies of MPS in WS patients have not been per-
formed [13]. In our study, findings consistent with
myocardial ischemia were detected in over one
fourth of the patients who underwent dipyridamole
SPECT MPS. SVAS of varying severity was present
in three fourths of 11 patients with positive MPS
results. When the data of ischemic patients compared
with the results of coronary CT angiography, 70%
of patients with anomalies on CT angiography had
ischemia on MPS and that the association was sta-
tistically highly significant. Notably, although one
patient had no pathology at the physical examination,
ECG and ECHO, coronary angiography revealed that
ostial stenosis was present and LMCA was located
superiorly, while MPS showed findings consistent
with ischemia. This case further supports the hy-
pothesis that even in WS patients SVAS may not be
present, but coronary artery involvement can be di-
rectly related to elastin arteriopathy.
Conclusions
Coronary artery anomalies are common in WS
patients and are often accompanied by SVAS. Tak-
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ing into consideration the risks involved in classic
cardiac catheterization, multidetector CT angiogra-
phy seems the ideal imaging method for detecting
coronary lesions. Dipyridamole 99mTc-sestamibi
SPECT MPS can also be used to screen myocar-
dial perfusion defects that can be the cause of coro-
nary artery complications.
Since most sudden deaths are related to biven-
tricular outflow tract stenosis and coronary anoma-
lies, early identification of the risk factors using
ECHO, CT angiography and MPS may prevent this
fatal prognosis. Cardiovascular follow-up protocols
including CT angiography and MPS can be imple-
mented in well-designed, multicentric, large cohort
studies, and relevant measures can be considered
to decrease the sudden death risk. After severral
studies reported on the positive outcome of the
preventure procedures, guidlines for the follow-up
of cardiovascular anomalies in WS patients can be
modified and inclusion of CT angiography and MPS
can be considered as the routine evaluation method.
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